PRIMIDONE (primidone) by Hikma is clinical pharmacology primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Approved for the control of grand mal, psychomotor, focal epileptic seizures. First approved in 2024.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. The mechanism(s) of primidone’s antiepileptic action is not known. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and…
Anti-epileptic Agent
Worked on PRIMIDONE at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo